Muscular Dystrophy Association (MDA): Translational Research (LOI)

Drug development program, which is exclusively focused on funding the discovery and clinical application of treatments and cures for neuromuscular diseases. MVP funds projects from proof-of-principle studies through phase 2 trials.

Funding ranges for:
Research and Development - up to $300K,
Preclinical - up to $500K 
Early Clinical (Phase I/II) -up to $1 million for 2 years.

https://www.mda.org/research/funding-opportunities